A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali

Issaka Sagara(University of Bamako), Alassane Dicko(University of Bamako), Ruth D. Ellis(National Institute of Allergy and Infectious Diseases), Michael P. Fay(National Institutes of Health), Sory Ibrahim Diawara(University of Bamako), Mahamadoun H. Assadou(University of Bamako), Mahamadou S. Sissoko(University of Bamako), Mamady Koné(University of Bamako), Abdoulbaki I. Diallo(University of Bamako), Rénion Saye(University of Bamako), Merepen A. Guindo(University of Bamako), Ousmane Kante(University of Bamako), Mohamed B. Niambele(University of Bamako), Kazutoyo Miura(National Institute of Allergy and Infectious Diseases), Gregory Mullen(Laboratoire d’Imagerie Biomédicale), Mark A. Pierce(National Institutes of Health), Laura B. Martin(National Institutes of Health), Amagana Dolo(University of Bamako), Dapa A. Diallo(University of Bamako), Ogobara K. Doumbo(University of Bamako), Louis H. Miller(National Institute of Allergy and Infectious Diseases), Allan Saul(National Institute of Allergy and Infectious Diseases)
Vaccine
March 26, 2009
10.1016/j.vaccine.2009.03.014
Cited by 179Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis